Once for Life

Once for Life

Creating transformational gene and peptide therapies that treat the most prevalent diseases to restore health and renew life

Renova Therapeutics envisions a future in which we’re able to permanently treat chronic diseases with gene and peptide therapies. Right now, we’re developing definitive treatments to restore health to people suffering from some of the most common and devastating chronic conditions in the world: congestive heart failure and type 2 diabetes.

Tell Us Who You Are, And We'll Guide You Through our Site


Latest News:  May 2, 2017: San Diego Business Journal | Big Pharma Execs Join Renova Leadership Team

  May 2, 2017: PRESS RELEASE | Industry leaders join Renova Therapeutics to lead preclinical programs into clinical development

  April 11, 2017: PRESS RELEASE | 'Human Gene Therapy' publishes review of randomized clinical trials of gene transfer for heart failure with reduced ejection fraction

View All News
Subscribe to receive company press releases and announcements